AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
PIROXICAM USP
6 registrations across 3 African markets— 4 active
Markets with PIROXICAM USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| PIRICAM 20 Capsules | 🇷🇼Rwanda | MMC HEALTHCARE LTD | active | Aug 2029 |
| PIRICAM-20 Capsules | 🇷🇼Rwanda | MMC Healthcare Ltd | active | Aug 2029 |
| PROXYREN CAPSULES Capsules | 🇷🇼Rwanda | RENE INDUSTRIES LTD | active | Aug 2029 |
| Poxicam gel Gel | 🇰🇪Kenya | Bio-Labs (Pvt.) Ltd. | active | May 2028 |
| FELMICAM 20 CAPSULES / 10 X 10 | 🇳🇬Nigeria | ST. MICHAEL PHARMACEUTICALS LTD. 17A | expired | Aug 2022 |
| FELMICAM CAPSULES TABLETS 10 X 10 | 🇳🇬Nigeria | ST. MICHEAL PHARM LTD 17A | expired | Nov 2021 |
PIROXICAM USP in Africa — Regulatory Overview
PIROXICAM USP is registered across 3 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Rwanda, Nigeria, Kenya. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 4 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.